Due to advances in technology and increased development of parenteral drugs, one of the fastest-growing choices for drug delivery in the pharmaceutical...
Altasciences | 24-Feb-2022
| Technical / White Paper
There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...
Signant’s eConsent solution helped a sponsor manage the consenting process complexities in their pediatric attention deficit hyperactivity disorder (ADHD)...
Now that the pharma industry and regulators have significant data on safety and efficacy of mRNA vaccines, many companies are looking beyond infectious...
Altasciences | 17-Jan-2022
| Technical / White Paper
There are many challenges associated with early drug discovery and development. Advancing your best candidate for regulatory submissions requires a careful...
This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...
eClinical Solutions | 12-Jan-2022
| Technical / White Paper
Being data-driven is top-of-mind for many life sciences companies, but actually turning that idea into action is easier said than done. To effectively...
Modern digital trials have sparked a new need within life sciences organizations for optimized and scalable clinical data processes & strategies. This...
With 1 in 10 Sponsors identifying a lack of technology integration as their biggest pain point, Deighton Liverpool, Ancillare’s Chief Information Officer...
This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...
The manufacture of a drug product for clinical trials is of critical importance. The formulation, manufacturing, and assessment of a drug candidate during...
How can clinical supply management benefit your trials? Download this eBook to explore how you can drive excellence within the forecasting process, as...
The recent pandemic inspired Bayer to a proof-of-concept (POC) study that identified a viable solution for replacing in-person site selection visits. The...
